← Main Index Directory
Semaglutide Profile
metabolicCompound Summary
A selective, single-receptor GLP-1 agonist structurally optimized with a C20 fatty diacid chain. This specific modification protects the peptide from rapid degradation by the DPP-4 enzyme.
Verified Structural Chain Mapping
HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG
Clinical Mechanism Insight
Q: What is the primary feature of Semaglutide in chemical research?
A: Semaglutide targets localized GLP-1 pathways to alter hindbrain appetite messaging vectors and reduce fasting glucagon release.